Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1): an open-label, phase 2 trial
Published Online: 2021-09-?
Journal: The Lancet Oncology•Publisher: Elsevier BV
Authors: A Douglas Laird•Adam Stirling•Akos Czibere•Arnulf Stenzl•Celestia S Higano•Consuelo Buttigliero•Cynthia G Healy•Elena Castro•Fred Saad•Giorgio V Scagliotti•Hsiang-Chun Chen•Inge M van Oort•Johann S de Bono•Karim Fizazi•Marielena Mata•Mark T Fleming•Niven Mehra•Tanya Dorff
